[
  {
    "ts": null,
    "headline": "Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?",
    "summary": "Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year. See why NVO stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=4fe54bbfebc31f417cd7dcae931ae9f44dd3b7b747daf83a6fcfe4de46a655be",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732490908,
      "headline": "Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?",
      "id": 131620765,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1665778558/image_1665778558.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year. See why NVO stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=4fe54bbfebc31f417cd7dcae931ae9f44dd3b7b747daf83a6fcfe4de46a655be"
    }
  },
  {
    "ts": null,
    "headline": "With Big Tech Not So Magnificent, And S&P-500 Capped, What's Next?",
    "summary": "The S&P 500 may not surpass 6,000 soon, with Big Tech not driving gains. Click here to read why any sell-off should be seen as a buying opportunity.",
    "url": "https://finnhub.io/api/news?id=545c86387da539e09ae74887a2a1a21fce498f3402655c940318110832f59fef",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732479600,
      "headline": "With Big Tech Not So Magnificent, And S&P-500 Capped, What's Next?",
      "id": 131620129,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/184697460/image_184697460.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The S&P 500 may not surpass 6,000 soon, with Big Tech not driving gains. Click here to read why any sell-off should be seen as a buying opportunity.",
      "url": "https://finnhub.io/api/news?id=545c86387da539e09ae74887a2a1a21fce498f3402655c940318110832f59fef"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly’s (LLY) Breakthroughs: Hedge Funds’ New Healthcare Favorite",
    "summary": "We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other most promising healthcare stocks according to hedge funds. The Healthcare Sector: Growth, Innovation, and the Impact of AI The healthcare […]",
    "url": "https://finnhub.io/api/news?id=c0a19327dde8d8d8348ed7c55782b126d2db3202e78ca9c933125fd8062b166c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732476142,
      "headline": "Eli Lilly’s (LLY) Breakthroughs: Hedge Funds’ New Healthcare Favorite",
      "id": 131618987,
      "image": "https://s.yimg.com/ny/api/res/1.2/UjoPACeXPFyN.4G.yM_TTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other most promising healthcare stocks according to hedge funds. The Healthcare Sector: Growth, Innovation, and the Impact of AI The healthcare […]",
      "url": "https://finnhub.io/api/news?id=c0a19327dde8d8d8348ed7c55782b126d2db3202e78ca9c933125fd8062b166c"
    }
  },
  {
    "ts": null,
    "headline": "5 Best CEFs This Month For 8.5% Yield (November 2024)",
    "summary": "Discover top closed-end funds for income investors with high distributions, reasonable returns, and solid track records in our monthly series.",
    "url": "https://finnhub.io/api/news?id=bba3c3339c569a1da2c8924164b8a431deab8cebc55c2b03052c9bd04d914c9d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732440600,
      "headline": "5 Best CEFs This Month For 8.5% Yield (November 2024)",
      "id": 131614642,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1310121198/image_1310121198.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Discover top closed-end funds for income investors with high distributions, reasonable returns, and solid track records in our monthly series.",
      "url": "https://finnhub.io/api/news?id=bba3c3339c569a1da2c8924164b8a431deab8cebc55c2b03052c9bd04d914c9d"
    }
  }
]